Trend
DailyDowntrend (starting)
4 hourDescending Triangle
1 hourStrong Bullish
15 minLeaning Bullish
5 minSymmetric Triangle
Daily trend turns up above $6.92
Key levels
Resistance$1.45
Resistance$1.29
Support$1.16
Support$1.05
Latest news & SEC filings
EarningsSonoma Pharmaceuticals releases Q2 FY2027 earnings report
EarningsSonoma Pharmaceuticals narrows quarterly loss as revenue climbs
All SNOA news →Sonoma Pharmaceuticals develops and manufactures stabilized hypochlorous acid (HOCl) products used as medical devices and consumer health items. Its products address dermatology, wound and first aid care, eye care, podiatry, animal health, and hard-surface disinfection. The company sells directly and through distribution partners in the United States and more than 50 other countries, serving hospitals, physicians, dermatology practices, retailers, and pet product channels.
Based on the company's 10-K filed Jun 16, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SNOA.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$4.44
24
Moat Score
NONE
2/9
Piotroski Score
-18.6
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
36.7%
3yr Revenue CAGR
13.7%
EPS Growth YoY
32.26%
FCF Growth YoY
-2355.4%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for SNOA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:41:02 | $1.20 | 6,247 | $$7K | SELL |
| 20:26:16 | $1.22 | 5,000 | $$6K | MIDPOINT |
| 20:26:12 | $1.22 | 5,000 | $$6K | MIDPOINT |
| 20:26:09 | $1.22 | 5,000 | $$6K | MIDPOINT |
| 20:26:05 | $1.22 | 4,700 | $$6K | BUY |
5 dark pool trades shown · $$32K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for Sonoma Pharmaceuticals, Inc. (SNOA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →Sonoma Pharmaceuticals, Inc. (SNOA) is at $1.24, up 8.77% (+$0.10) at the Nov 11, 2026 close.
Latest SNOA news — Nov 11, 2026: Sonoma Pharmaceuticals releases Q2 FY2027 earnings report · Nov 10, 2026: Sonoma Pharmaceuticals narrows quarterly loss as revenue climbs
SNOA last reported on Aug 6, 2026: EPS $0.02 vs -$0.30 expected — a beat of 106.7%.
SNOA does not currently pay a dividend.
Support: $1.16, $1.05, $0.85. Resistance: $1.29, $1.45, $1.75.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
Nov 11, 2026: Sonoma Pharmaceuticals releases Q2 FY2027 earnings report · Nov 10, 2026: Sonoma Pharmaceuticals narrows quarterly loss as revenue climbs